SCI 발표논문

SCI 발표논문

← SCI 발표논문 목록

J Neurogastroenterol Motil. 2021;27(3):314-325.

Roles of Sex Hormones and Gender in the Gut Microbiota.

,

제1저자 윤기철 · 교신저자 김나영

소속 (3)
  1. Department of Internal Medicine, Wonkwang University Sanbon Medical Center, Gunpo, Gyeonggi-do, Korea.
  2. Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea.
  3. Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.

Abstract

The distribution of gut microbiota varies according to age (childhood, puberty, pregnancy, menopause, and old age) and sex. Gut microbiota are known to contribute to gastrointestinal (GI) diseases such as irritable bowel syndrome, inflammatory bowel disease, and colon cancer; however, the exact etiology remains elusive. Recently, sex and gender differences in GI diseases and their relation to gut microbiota has been suggested. Furthermore, the metabolism of estrogen and androgen was reported to be related to the gut microbiome. As gut microbiome is involved in the excretion and circulation process of sex hormones, the concept of "microgenderome" indicating the role of sex hormone on the gut microbiota has been suggested. However, further research is needed for this concept to be universally accepted. In this review, we summarize sex- and gender-differences in gut microbiota and the interplay of microbiota and GI diseases, focusing on sex hormones. We also describe the metabolic role of the microbiota in this regard. Finally, current subjects, such as medication including probiotics, are briefly discussed.

Keywords

Gastrointestinal diseasesGenderGutMicrobiotaSex hormones

Figures

Figure 1
Figure 1 Overview of endocrine physiology. Gonadotropin-releasing hormone (GnRH). LH, luteinizing hormone; FSH, follicle-stimulating hormone; TSH, thyroid-stimulating hormone; ACTH, adrenocorticotropic hormone; GH, growth hormone; Prl, prolactin. Adapted from Molina.12
Figure 2
Figure 2 Estrobolome: gene repertoire of intestinal microbiota with the ability of estrogen metabolism. β-glucuronidase from microbiota deconjugates estrogen. The “active” deconjugated and unbound estrogens act on estrogen receptor alpha (ERα) and ERβ. Adapted from Kwa et al.10
Figure 3
Figure 3 Molecular pathway of estrogen receptor (ER) action. Typically, estrogen binds to the ligand-binding domain of receptors in the nucleus, which causes a conformational change. Estrogen-responsive elements (ERE) mediate genomic effects. RE, response element; TF, transcription factor; GF, growth factor; GF-R, growth factor receptor; CoA, co-activator; CoR, co-repressor; MAPK, mictogen-activated protein kinase; PI3K, phophoinositide 3-kinase; Src, proto-oncogene tyrosine-protein kinase; AP-1, activating protein-1; Sp-1, stimulating protein-1. Adapted from Nie et al.16
Figure 4
Figure 4 Sex hormone and brain–gut axis in irritable bowel syndrome (IBS). E, estradiol; T, testosterone; P, progesterone; HPA, hypothalamic-pituitary-adrenal; CRH, corticotropin-releasing hormone; ACTH, adrenocorticotropic hormone; CNS, central nervous system; RhoA, Ras homolog family member A; GTP, guanosine-5’-triphosphate; CCK, cholecystokinin; PGE2, prostaglandin E2; IBS-D, IBS with diarrhea; 5-HT, 5-hydroxytryptamine; ER, estrogen receptor; DRG, dorsal root ganglion; JAM-A, junctional adhesion molecule-A. Adapted from Kim and Kim.84

그림 출처: PubMed Central 공개 논문 (PMC8266488)

Conflict of interest statement

Conflicts of interest: None.

그 밖의 정보
출판 형태
Journal Article, Review
저널
Journal of neurogastroenterology and motility · ISSN 2093-0879
참고문헌
93편